Haemonetics Corp (HAE) 42.94 $HAE
Haemonetics Up 18.0% Since SmarTrend Uptrend Call (HAE)
Comtex SmarTrend(R) - Thu Feb 12, 4:51PM CST
SmarTrend identified an Uptrend for Haemonetics (NYSE:HAE) on October 28th, 2014 at $36.90. In approximately 4 months, Haemonetics has returned 17.95% as of today's recent price of $43.53.
HAE: 42.94 (-0.59)
17 Healthcare Companies To Consider Based On Patent Dynamics And IP/Patent Indexes
Innovalpha - Seeking Alpha - Tue Feb 10, 8:08AM CST
Introduction We will present here a few healthcare stocks that have been recently selected by our IP models. As already explained in our SA article " Patent Dynamics And Stock Performance ", Innovalpha has developed proprietary IP and...
SGYP: 2.98 (unch), INSM: 17.40 (+0.69), RNN: 0.75 (+0.01), ZSPH: 46.77 (+3.42), RDHL: 12.69 (+0.04), ASPX: 65.76 (+2.76), ACUR: 0.55 (+0.01), XNPT: 6.69 (-0.21), SPNC: 33.69 (-0.06), CORI: 7.00 (-0.05), SAGE: 41.03 (-0.07), EBIO: 10.13 (+0.05), HAE: 42.94 (-0.59), JAZZ: 169.69 (+6.89), ICPT: 209.12 (+7.12), NVDQ: 15.12 (+0.51)
Shares of HAE Up 14.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 05, 11:21AM CST
SmarTrend identified an Uptrend for Haemonetics (NYSE:HAE) on October 28th, 2014 at $36.91. In approximately 3 months, Haemonetics has returned 14.05% as of today's recent price of $42.09.
HAE: 42.94 (-0.59)
Haemonetics Q3 Earnings Top Estimates, Drop Y/Y; Stock Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 9:00AM CST
Although Haemonetics' (HAE) earnings topped the Zacks Consensus Estimate, it reflected a significant slash year-over-year. With the bleak performance of blood center as well as hospital disposable businesses, the top line too failed to meet our expectation
ICUI: 88.98 (+0.42), CSII: 35.69 (+0.17), ABAX: 60.93 (+0.65), HAE: 42.94 (-0.59)
Haemonetics (HAE) in Focus: Stock Adds 6.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 8:25AM CST
Haemonetics (HAE) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 88.98 (+0.42), HAE: 42.94 (-0.59)
Haemonetics' (HAE) CEO Brian Concannon on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 29, 3:01PM CST
HAE: 42.94 (-0.59)
Haemonetics (HAE) Q3 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Jan 29, 8:55AM CST
HAE: 42.94 (-0.59)
Haemonetics beats 3Q profit forecasts
Automated Insights - Thu Jan 29, 8:09AM CST
BRAINTREE, Mass. (AP) _ Haemonetics Corp. (HAE) on Thursday reported fiscal third-quarter net income of $16 million.
HAE: 42.94 (-0.59)
Haemonetics beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 7:13AM CST
HAE: 42.94 (-0.59)
Haemonetics Reports 3rd Quarter Fiscal 2015 Revenue of $232 Million and Adjusted EPS of $0.53; Reaffirms Revenue and EPS Guidance
PR Newswire - Thu Jan 29, 7:00AM CST
Haemonetics Corporation (NYSE: HAE) today reported third quarter fiscal 2015 revenue of $231.8 million, down 4.3%. In constant currency, revenue declined 1.4% in the quarter. The Company reported third quarter GAAP net income of $16.0 million and GAAP net income per share of $0.31. Exclusive of transformation, restructuring and deal amortization expenses detailed below, adjusted net income was $27.5 million and adjusted earnings per share were $0.53, both down 14%.[1]
HAE: 42.94 (-0.59)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 4:30PM CST
HOG: 63.90 (+0.82), CAM: 47.45 (+1.45), CRR: 40.35 (+2.73), HSY: 106.02 (-0.64), NOC: 167.14 (-0.15), CAH: 86.08 (+0.04), HP: 69.58 (+3.62), AIT: 42.60 (+0.09), NOK: 8.02 (+0.05), COH: 39.85 (+0.64), ITG: 21.99 (-0.19), CLFD: 13.57 (-0.03), MD: 71.32 (-0.06), CSH: 20.53 (-0.31), PSX: 76.62 (+1.51), HAR: 136.40 (-3.18), NYCB: 16.37 (+0.07), LSTR: 68.62 (-0.05), ALV: 113.36 (-0.26), POT: 37.04 (+0.04), IVZ: 39.52 (-0.06), COP: 69.88 (+1.84), LRN: 16.56 (-0.06), CELG: 115.88 (+0.16), MJN: 101.89 (+2.32), GLOP: 24.02 (+0.35), HAE: 42.94 (-0.59), DGX: 71.68 (+0.03), ALXN: 182.29 (+6.02), NDAQ: 49.48 (-0.27), DOW: 49.44 (+0.29), DST: 108.31 (-0.35), CHKP: 80.33 (+2.13), EPD: 34.44 (+0.19), F: 16.30 (-0.06), BX: 37.40 (+0.49), ALLY: 22.05 (+0.21), KEM: 4.31 (+0.08), OSTK: 22.45 (-0.13), MMYT: 24.55 (+0.09), JBLU: 16.83 (+0.09), DHX: 8.56 (unch), KMT: 35.44 (+0.86), BC: 55.30 (+0.61), EMC: 27.99 (+0.12), OXY: 83.11 (+1.07), APD: 152.81 (+0.59), CMS: 34.65 (-0.88), ABT: 46.09 (+0.87), HGG: 6.78 (+0.34), BMS: 47.04 (-0.03), PENN: 16.62 (-0.21), BAX: 70.39 (+0.31), PHM: 22.89 (+0.02), BEAV: 62.70 (+2.08), MTH: 41.94 (-0.09), HUB.B: 115.41 (+0.55), LLL: 129.45 (+0.19), CL: 70.08 (+0.23), BABA: 89.05 (+1.95), KELYA: 18.00 (+0.01)
Haemonetics moves earnings report out a day
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 12:01PM CST
HAE: 42.94 (-0.59)
Due To Winter Storm, Haemonetics Moves Announcement of Third Quarter Fiscal 2015 Earnings Results To Thursday, January 29
PR Newswire - Mon Jan 26, 9:58AM CST
Considering the impact of the severe winter storm expected this week on the East Coast, Haemonetics Corporation (NYSE: HAE) will delay by one day the release of its third quarter fiscal 2015 earnings results until 8:00am Thursday, January 29. The press release will also be available on the Company's website at www.haemonetics.com.
HAE: 42.94 (-0.59)
Haemonetics reports January 28
Seeking Alpha - at Seeking Alpha - Mon Dec 29, 7:50AM CST
HAE: 42.94 (-0.59)
Haemonetics Sets Date for Third Quarter Fiscal Year 2015 Earnings Release: January 28, 2015
PR Newswire - Mon Dec 29, 7:00AM CST
Haemonetics Corporation (NYSE:HAE) will announce its earnings for the third quarter of its fiscal year 2015 on January 28, 2015 in a pre-market press release. The Company will host a webcast to discuss and answer questions about the press release at 8:00 am eastern time on January 28, 2015.
HAE: 42.94 (-0.59)
Haemonetics Q2 Results Let Down by Poor Disposables Show - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 26, 1:40PM CST
On Dec 19, 2014, we issued an updated research report on blood management solutions provider, Haemonetics Corporation (HAE).
ICUI: 88.98 (+0.42), INSY: 51.50 (-0.66), HAE: 42.94 (-0.59), OSUR: 8.13 (+0.06)
Haemonetics to Present at the 33rd Annual J.P. Morgan Health Care Conference
PR Newswire - Mon Dec 22, 3:00PM CST
Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the 33rd Annual J.P. Morgan Health Care Conference in San Francisco on Tuesday, January 13, 2015 at 4:30 pm Pacific time / 7:30 pm Eastern time.
JPM: 59.67 (+0.10), HAE: 42.94 (-0.59)
Haemonetics (HAE) Upgraded From Hold to Buy
at The Street - Sat Dec 13, 7:20AM CST
Haemonetics (HAE) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
HAE: 42.94 (-0.59)
Post Earnings Update: Haemonetics Has Climbed 6.9% Higher in Past 2 Weeks (HAE)
Comtex SmarTrend(R) - Mon Nov 17, 8:53AM CST
When Haemonetics (NYSE:HAE) reported earnings 14 days ago on November 3rd, 2014, analysts, on average, expected the company to report earnings of $0.45 on sales of $230.0 million. The company actually reported EPS of $0.47 on sales of $227.6 million, beating EPS estimates by $0.02 and missing revenue estimates by $2.4 million. Shares of Haemonetics have climbed from $34.74 to $37.13, representing a gain of 6.9% since the company reported earnings 14 days ago.
HAE: 42.94 (-0.59)
Haemonetics to Present at the Jefferies 2014 Global Healthcare Conference
PR Newswire - Tue Nov 11, 3:00PM CST
Haemonetics Corporation (NYSE: HAE) announced today that Gerry Gould, Vice President, Investor Relations, will present at the Jefferies 2014 Global Healthcare Conference in London, England on November 20, 2014 at 8:40 am GMT.
HAE: 42.94 (-0.59)
Haemonetics Up 18.0% Since SmarTrend Uptrend Call (HAE)
Comtex SmarTrend(R) - Thu Feb 12, 4:51PM CST
SmarTrend identified an Uptrend for Haemonetics (NYSE:HAE) on October 28th, 2014 at $36.90. In approximately 4 months, Haemonetics has returned 17.95% as of today's recent price of $43.53.
HAE: 42.94 (-0.59)
17 Healthcare Companies To Consider Based On Patent Dynamics And IP/Patent Indexes
Innovalpha - Seeking Alpha - Tue Feb 10, 8:08AM CST
Introduction We will present here a few healthcare stocks that have been recently selected by our IP models. As already explained in our SA article " Patent Dynamics And Stock Performance ", Innovalpha has developed proprietary IP and...
SGYP: 2.98 (unch), INSM: 17.40 (+0.69), RNN: 0.75 (+0.01), ZSPH: 46.77 (+3.42), RDHL: 12.69 (+0.04), ASPX: 65.76 (+2.76), ACUR: 0.55 (+0.01), XNPT: 6.69 (-0.21), SPNC: 33.69 (-0.06), CORI: 7.00 (-0.05), SAGE: 41.03 (-0.07), EBIO: 10.13 (+0.05), HAE: 42.94 (-0.59), JAZZ: 169.69 (+6.89), ICPT: 209.12 (+7.12), NVDQ: 15.12 (+0.51)
Shares of HAE Up 14.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 05, 11:21AM CST
SmarTrend identified an Uptrend for Haemonetics (NYSE:HAE) on October 28th, 2014 at $36.91. In approximately 3 months, Haemonetics has returned 14.05% as of today's recent price of $42.09.
HAE: 42.94 (-0.59)
Haemonetics Q3 Earnings Top Estimates, Drop Y/Y; Stock Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 9:00AM CST
Although Haemonetics' (HAE) earnings topped the Zacks Consensus Estimate, it reflected a significant slash year-over-year. With the bleak performance of blood center as well as hospital disposable businesses, the top line too failed to meet our expectation
ICUI: 88.98 (+0.42), CSII: 35.69 (+0.17), ABAX: 60.93 (+0.65), HAE: 42.94 (-0.59)
Haemonetics (HAE) in Focus: Stock Adds 6.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 8:25AM CST
Haemonetics (HAE) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 88.98 (+0.42), HAE: 42.94 (-0.59)
Haemonetics' (HAE) CEO Brian Concannon on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 29, 3:01PM CST
HAE: 42.94 (-0.59)
Haemonetics (HAE) Q3 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Jan 29, 8:55AM CST
HAE: 42.94 (-0.59)
Haemonetics beats 3Q profit forecasts
Automated Insights - Thu Jan 29, 8:09AM CST
BRAINTREE, Mass. (AP) _ Haemonetics Corp. (HAE) on Thursday reported fiscal third-quarter net income of $16 million.
HAE: 42.94 (-0.59)
Haemonetics beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 7:13AM CST
HAE: 42.94 (-0.59)
Haemonetics Reports 3rd Quarter Fiscal 2015 Revenue of $232 Million and Adjusted EPS of $0.53; Reaffirms Revenue and EPS Guidance
PR Newswire - Thu Jan 29, 7:00AM CST
Haemonetics Corporation (NYSE: HAE) today reported third quarter fiscal 2015 revenue of $231.8 million, down 4.3%. In constant currency, revenue declined 1.4% in the quarter. The Company reported third quarter GAAP net income of $16.0 million and GAAP net income per share of $0.31. Exclusive of transformation, restructuring and deal amortization expenses detailed below, adjusted net income was $27.5 million and adjusted earnings per share were $0.53, both down 14%.[1]
HAE: 42.94 (-0.59)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 4:30PM CST
HOG: 63.90 (+0.82), CAM: 47.45 (+1.45), CRR: 40.35 (+2.73), HSY: 106.02 (-0.64), NOC: 167.14 (-0.15), CAH: 86.08 (+0.04), HP: 69.58 (+3.62), AIT: 42.60 (+0.09), NOK: 8.02 (+0.05), COH: 39.85 (+0.64), ITG: 21.99 (-0.19), CLFD: 13.57 (-0.03), MD: 71.32 (-0.06), CSH: 20.53 (-0.31), PSX: 76.62 (+1.51), HAR: 136.40 (-3.18), NYCB: 16.37 (+0.07), LSTR: 68.62 (-0.05), ALV: 113.36 (-0.26), POT: 37.04 (+0.04), IVZ: 39.52 (-0.06), COP: 69.88 (+1.84), LRN: 16.56 (-0.06), CELG: 115.88 (+0.16), MJN: 101.89 (+2.32), GLOP: 24.02 (+0.35), HAE: 42.94 (-0.59), DGX: 71.68 (+0.03), ALXN: 182.29 (+6.02), NDAQ: 49.48 (-0.27), DOW: 49.44 (+0.29), DST: 108.31 (-0.35), CHKP: 80.33 (+2.13), EPD: 34.44 (+0.19), F: 16.30 (-0.06), BX: 37.40 (+0.49), ALLY: 22.05 (+0.21), KEM: 4.31 (+0.08), OSTK: 22.45 (-0.13), MMYT: 24.55 (+0.09), JBLU: 16.83 (+0.09), DHX: 8.56 (unch), KMT: 35.44 (+0.86), BC: 55.30 (+0.61), EMC: 27.99 (+0.12), OXY: 83.11 (+1.07), APD: 152.81 (+0.59), CMS: 34.65 (-0.88), ABT: 46.09 (+0.87), HGG: 6.78 (+0.34), BMS: 47.04 (-0.03), PENN: 16.62 (-0.21), BAX: 70.39 (+0.31), PHM: 22.89 (+0.02), BEAV: 62.70 (+2.08), MTH: 41.94 (-0.09), HUB.B: 115.41 (+0.55), LLL: 129.45 (+0.19), CL: 70.08 (+0.23), BABA: 89.05 (+1.95), KELYA: 18.00 (+0.01)
Haemonetics moves earnings report out a day
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 12:01PM CST
HAE: 42.94 (-0.59)
Due To Winter Storm, Haemonetics Moves Announcement of Third Quarter Fiscal 2015 Earnings Results To Thursday, January 29
PR Newswire - Mon Jan 26, 9:58AM CST
Considering the impact of the severe winter storm expected this week on the East Coast, Haemonetics Corporation (NYSE: HAE) will delay by one day the release of its third quarter fiscal 2015 earnings results until 8:00am Thursday, January 29. The press release will also be available on the Company's website at www.haemonetics.com.
HAE: 42.94 (-0.59)
Haemonetics reports January 28
Seeking Alpha - at Seeking Alpha - Mon Dec 29, 7:50AM CST
HAE: 42.94 (-0.59)
Haemonetics Sets Date for Third Quarter Fiscal Year 2015 Earnings Release: January 28, 2015
PR Newswire - Mon Dec 29, 7:00AM CST
Haemonetics Corporation (NYSE:HAE) will announce its earnings for the third quarter of its fiscal year 2015 on January 28, 2015 in a pre-market press release. The Company will host a webcast to discuss and answer questions about the press release at 8:00 am eastern time on January 28, 2015.
HAE: 42.94 (-0.59)
Haemonetics Q2 Results Let Down by Poor Disposables Show - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 26, 1:40PM CST
On Dec 19, 2014, we issued an updated research report on blood management solutions provider, Haemonetics Corporation (HAE).
ICUI: 88.98 (+0.42), INSY: 51.50 (-0.66), HAE: 42.94 (-0.59), OSUR: 8.13 (+0.06)
Haemonetics to Present at the 33rd Annual J.P. Morgan Health Care Conference
PR Newswire - Mon Dec 22, 3:00PM CST
Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the 33rd Annual J.P. Morgan Health Care Conference in San Francisco on Tuesday, January 13, 2015 at 4:30 pm Pacific time / 7:30 pm Eastern time.
JPM: 59.67 (+0.10), HAE: 42.94 (-0.59)
Haemonetics (HAE) Upgraded From Hold to Buy
at The Street - Sat Dec 13, 7:20AM CST
Haemonetics (HAE) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
HAE: 42.94 (-0.59)
Post Earnings Update: Haemonetics Has Climbed 6.9% Higher in Past 2 Weeks (HAE)
Comtex SmarTrend(R) - Mon Nov 17, 8:53AM CST
When Haemonetics (NYSE:HAE) reported earnings 14 days ago on November 3rd, 2014, analysts, on average, expected the company to report earnings of $0.45 on sales of $230.0 million. The company actually reported EPS of $0.47 on sales of $227.6 million, beating EPS estimates by $0.02 and missing revenue estimates by $2.4 million. Shares of Haemonetics have climbed from $34.74 to $37.13, representing a gain of 6.9% since the company reported earnings 14 days ago.
HAE: 42.94 (-0.59)
Haemonetics to Present at the Jefferies 2014 Global Healthcare Conference
PR Newswire - Tue Nov 11, 3:00PM CST
Haemonetics Corporation (NYSE: HAE) announced today that Gerry Gould, Vice President, Investor Relations, will present at the Jefferies 2014 Global Healthcare Conference in London, England on November 20, 2014 at 8:40 am GMT.
HAE: 42.94 (-0.59)
